Detalhe da pesquisa
1.
Sensitization to textile dyes in Spain: Epidemiological situation (2019-2022).
Contact Dermatitis
; 90(5): 486-494, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38348533
2.
2-Hydroxyethyl methacrylate (2-HEMA) sensitization, a global epidemic at its peak in Spain?
Contact Dermatitis
; 90(5): 507-513, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38351475
3.
Sensitization to isothiazolinones in the Spanish Contact Dermatitis Registry (REIDAC): 2019-2021 epidemiological situation.
Contact Dermatitis
; 88(3): 212-219, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36403138
4.
Unmet Needs in the Management of Moderate-to-Severe Psoriasis in Spain: A Multidimensional Evaluation.
Acta Derm Venereol
; 102: adv00678, 2022 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35312022
5.
Correction: Vidal et al. From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment. Int. J. Mol. Sci. 2021, 22, 6740.
Int J Mol Sci
; 23(5)2022 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35270045
6.
From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment.
Int J Mol Sci
; 22(13)2021 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34201664
7.
Allergic contact dermatitis to alkyl glucosides: Epidemiological situation in Spain.
J Eur Acad Dermatol Venereol
; 37(3): e334-e337, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36153692
8.
Sodium metabisulfite a current low relevant allergen in Spain.
J Eur Acad Dermatol Venereol
; 2023 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38088580
9.
The social value of a PASI 90 or PASI 100 response in patients with moderate-to-severe plaque psoriasis in Spain.
Front Public Health
; 11: 1000776, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36778548
10.
PASI 100 response rates in moderate to severe psoriasis: a systematic literature review and analysis of clinical practice guidelines.
J Dermatolog Treat
; 33(3): 1661-1669, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33615959
11.
Quantifying Physician Preferences for Systemic Atopic Dermatitis Treatments Using a Discrete-Choice Experiment.
Dermatol Ther (Heidelb)
; 12(5): 1197-1210, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35445962
12.
Assessing the value contribution of bimekizumab for the treatment of moderate-to-severe psoriasis using a multidisciplinary reflective multi-criteria decision analysis.
Expert Rev Pharmacoecon Outcomes Res
; 22(6): 941-953, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35404728
13.
Therapeutic goals and treatment response evaluation in moderate to severe psoriasis: an experts opinion document.
Ann Med
; 53(1): 1727-1736, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34601988
14.
Ixekizumab for the treatment of erythrodermic psoriasis triggered by durvalumab-tremelimumab in a cancer patient.
Eur J Dermatol
; 2021 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34463279